{ "cik": 1609550, "cik_padded": "0001609550", "entityName": "Inspire Medical Systems, Inc.", "fiscal_years": [ { "accn": "0001609550-26-000016", "filed": "2026-02-13", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 175019000.0, "capex": 38499000.0, "cash": 104813000.0, "cost_of_revenue": 133225000.0, "eps_diluted": 4.89, "free_cash_flow": 78477000.0, "gross_profit": 778756000.0, "net_income": 145422000.0, "operating_cash_flow": 116976000.0, "operating_income": 50954000.0, "revenue": 911981000.0, "stockholders_equity": 781160000.0, "total_assets": 907317000.0, "total_liabilities": 126157000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8539169127426997, "leverage": 0.1614995647498592, "net_margin": 0.1594572693948668, "operating_margin": 0.05587177803046335, "revenue_growth_yoy": 0.13599458896567532, "roa_avg2y": 0.16951914670396923, "roa_period_end": 0.16027694840943135, "roe_avg2y": 0.1977380503176724, "roe_period_end": 0.18616160581699012 } }, { "accn": "0001609550-26-000016", "filed": "2026-02-13", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 39123000.0, "cash": 150150000.0, "cost_of_revenue": 122986000.0, "eps_diluted": 1.75, "free_cash_flow": 91123000.0, "gross_profit": 679818000.0, "net_income": 53509000.0, "operating_cash_flow": 130246000.0, "operating_income": 36083000.0, "revenue": 802804000.0, "stockholders_equity": 689695000.0, "total_assets": 808383000.0, "total_liabilities": 118688000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8468044504013433, "leverage": 0.17208766193752312, "net_margin": 0.06665263252300686, "operating_margin": 0.04494621352160677, "revenue_growth_yoy": 0.284899623718988, "roa_avg2y": 0.07205657981381557, "roa_period_end": 0.06619263393713129, "roe_avg2y": 0.08478627549003374, "roe_period_end": 0.07758356954885855 } }, { "accn": "0001609550-26-000016", "filed": "2026-02-13", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 23629000.0, "cash": 185537000.0, "cost_of_revenue": 96576000.0, "eps_diluted": -0.72, "free_cash_flow": 1024000.0, "gross_profit": 528223000.0, "net_income": -21153000.0, "operating_cash_flow": 24653000.0, "operating_income": -40271000.0, "revenue": 624799000.0, "stockholders_equity": 572514000.0, "total_assets": 676811000.0, "total_liabilities": 104297000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8454286898666611, "leverage": 0.18217371103588734, "net_margin": -0.033855687989257345, "operating_margin": -0.06445432851204948, "revenue_growth_yoy": 0.5319107724294849, "roa_avg2y": -0.034071388361157036, "roa_period_end": -0.03125392465547989, "roe_avg2y": -0.0395930079118633, "roe_period_end": -0.03694756809440468 } }, { "accn": "0001609550-26-000016", "filed": "2026-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 9096000.0, "cash": 441592000.0, "cost_of_revenue": 66115000.0, "eps_diluted": -1.6, "free_cash_flow": 2473000.0, "gross_profit": 341741000.0, "net_income": -44881000.0, "operating_cash_flow": 11569000.0, "operating_income": -47592000.0, "revenue": 407856000.0, "stockholders_equity": 496008000.0, "total_assets": 564876000.0, "total_liabilities": 68868000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.837896218273116, "leverage": 0.1388445347655683, "net_margin": -0.11004128908242125, "operating_margin": -0.11668824290926211, "revenue_growth_yoy": 0.7474999357309956, "roa_avg2y": -0.10437927345457929, "roa_period_end": -0.07945283566658877, "roe_avg2y": -0.12380009268249625, "roe_period_end": -0.09048442767052144 } }, { "accn": "0001609550-25-000011", "filed": "2025-02-10", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4668000.0, "cash": 214467000.0, "cost_of_revenue": 33279000.0, "eps_diluted": -1.54, "free_cash_flow": -24787000.0, "gross_profit": 200115000.0, "net_income": -42042000.0, "operating_cash_flow": -20119000.0, "operating_income": -39850000.0, "revenue": 233394000.0, "stockholders_equity": 229048000.0, "total_assets": 295084000.0, "total_liabilities": 66036000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8574127869611043, "leverage": 0.288306381195208, "net_margin": -0.180133165377002, "operating_margin": -0.17074132154211333, "revenue_growth_yoy": 1.0228113814232846, "roa_avg2y": -0.14591001140084647, "roa_period_end": -0.14247468517439102, "roe_avg2y": -0.18327139572140064, "roe_period_end": -0.1835510460689463 } }, { "accn": "0001609550-24-000016", "filed": "2024-02-09", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2455000.0, "cash": 190518000.0, "cost_of_revenue": 17623000.0, "eps_diluted": -2.19, "free_cash_flow": -55500000.0, "gross_profit": 97758000.0, "net_income": -57203000.0, "operating_cash_flow": -53045000.0, "operating_income": -56208000.0, "revenue": 115381000.0, "stockholders_equity": 229747000.0, "total_assets": 281189000.0, "total_liabilities": 51442000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8472625475598236, "leverage": 0.22390716744941175, "net_margin": -0.49577486761251854, "operating_margin": -0.48715126407294096, "revenue_growth_yoy": 0.4062279098110908, "roa_avg2y": -0.24739534903836588, "roa_period_end": -0.20343256670780152, "roe_avg2y": -0.3095551190263595, "roe_period_end": -0.24898257648630884 } }, { "accn": "0001609550-23-000024", "filed": "2023-02-10", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2739000.0, "cash": 22860000.0, "cost_of_revenue": 13643000.0, "eps_diluted": -1.4, "free_cash_flow": -35585000.0, "gross_profit": 68407000.0, "net_income": -33243000.0, "operating_cash_flow": -32846000.0, "operating_income": -34897000.0, "revenue": 82050000.0, "stockholders_equity": 139835000.0, "total_assets": 181253000.0, "total_liabilities": 41418000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8337233394271786, "leverage": 0.2961919405013051, "net_margin": -0.40515539305301645, "operating_margin": -0.42531383302864106, "revenue_growth_yoy": 0.6217658569367304, "roa_avg2y": -0.17435155100660052, "roa_period_end": -0.18340661947664313, "roe_avg2y": -0.21882343648176306, "roe_period_end": -0.23773018200021453 } }, { "accn": "0001609550-22-000014", "filed": "2022-02-15", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 250000.0, "cash": 97288000.0, "cost_of_revenue": 10056000.0, "free_cash_flow": -18944000.0, "gross_profit": 40537000.0, "net_income": -21828000.0, "operating_cash_flow": -18694000.0, "operating_income": -20378000.0, "revenue": 50593000.0, "stockholders_equity": 163999000.0, "total_assets": 200080000.0, "total_liabilities": 36081000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8012373253216848, "leverage": 0.22000743906975043, "net_margin": -0.43144308501176054, "operating_margin": -0.40278299369477993, "roa_period_end": -0.10909636145541785, "roe_avg2y": -0.2640600994398945, "roe_period_end": -0.13309837255105214 } }, { "accn": "0001609550-21-000010", "filed": "2021-02-24", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 412000.0, "free_cash_flow": -16203000.0, "gross_profit": 22549000.0, "net_income": -17511000.0, "operating_cash_flow": -15791000.0, "operating_income": -16003000.0, "stockholders_equity": 1327000.0 }, "period_end": "2017-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": 6.631698541942814 } }, { "accn": "0001609550-20-000011", "filed": "2020-02-25", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -6608000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001609550-26-000016", "filed": "2026-02-13", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001609550.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001609550.json" }, "ticker": "INSP" }